Impact of performance status on non-small-cell lung cancer patients with a PD-L1 tumour proportion score ≥50% treated with front-line pembrolizumab

Friedlaender, Alex; Metro, Giulio; Signorelli, Diego; Gili, Alessio; Economopoulou, Panagiota; Roila, Fausto; Banna, Giuseppe; De Toma, Alessandro; Camerini, Andrea; Christopoulou, Athina; Lo Russo, Giuseppe; Banini, Marco; Galetta, Domenico; Jimenez, Beatriz; Collazo-Lorduy, Ana; Calles, Antonio; Baxevanos, Panagiotis; Linardou, Helena; Kosmidis, Paris; Mountzios, Giannis; Garassino, Marina C.; Addeo, Alfredo

doi:10.1080/0284186x.2020.1781249

Back

Journal article

Impact of performance status on non-small-cell lung cancer patients with a PD-L1 tumour proportion score ≥50% treated with front-line pembrolizumab

Friedlaender, Alex Department of Oncology, Geneva University Hospital, Geneva, Switzerland;
Metro, Giulio Santa Maria della Misericordia Hospital, Azienda Ospedaliera di Perugia, Perugia, Italy;
Signorelli, Diego Medical Oncology Department, Fondazione IRCCS, Istituto Nazionale Tumori di Milano, Milano, Italy;
Gili, Alessio Public Health Section, Department of Experimental Medicine, University of Perugia, Perugia, Italy;
Economopoulou, Panagiota Oncology Department, Attikon University Hospital, Athens, Greece;
Roila, Fausto Santa Maria della Misericordia Hospital, Azienda Ospedaliera di Perugia, Perugia, Italy;
Banna, Giuseppe Medical Oncology, Ospedale Cannizzaro, Catania, Italy;
De Toma, Alessandro Medical Oncology Department, Fondazione IRCCS, Istituto Nazionale Tumori di Milano, Milano, Italy;
Camerini, Andrea U.O.C. Oncologia, Ospedale Versilia, Lido di Camaiore (LU), Italy;
Christopoulou, Athina Medical Oncology, Agios Andreas General Hospital of Patras, Patras, Greece;
Lo Russo, Giuseppe Medical Oncology Department, Fondazione IRCCS, Istituto Nazionale Tumori di Milano, Milano, Italy;
Banini, Marco Santa Maria della Misericordia Hospital, Azienda Ospedaliera di Perugia, Perugia, Italy;
Galetta, Domenico Medical Thoracic Oncology Unit, IRCCS Istituto Tumori “Giovanni Paolo II”, Bari, Italy;
Jimenez, Beatriz Medical Oncology, Hospital Universitario HM Sanchinarro, Madrid, Spain;
Collazo-Lorduy, Ana Medical Oncology, Hospital Universitario HM Sanchinarro, Madrid, Spain;
Calles, Antonio Division of Medical Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain;
Baxevanos, Panagiotis Second Department of Medical Oncology, Saint Savvas Anti-Cancer Hospital, Athens, Greece;
Linardou, Helena First Department of Medical Oncology, Metropolitan Hospital, Athens, Greece;
Kosmidis, Paris Second Department of Medical Oncology, Hygeia Hospital, Athens, Greece;
Mountzios, Giannis Second Department of Medical Oncology, Henry Dunant Hospital Center, Athens, Greece
Garassino, Marina C. Medical Oncology Department, Fondazione IRCCS, Istituto Nazionale Tumori di Milano, Milano, Italy;
Addeo, Alfredo ORCID Department of Oncology, Geneva University Hospital, Geneva, Switzerland;